-
Views
-
Cite
Cite
Michael J. Hawkins, Michael A. Friedman, National Cancer Institute's Evaluation of Unconventional Cancer Treatments, JNCI: Journal of the National Cancer Institute, Volume 84, Issue 22, 18 November 1992, Pages 1699–1702, https://doi.org/10.1093/jnci/84.22.1699
- Share Icon Share
Abstract
Unconventional cancer treatments are associated with considerable controversy. Opponents cite the unsubstantiated claims of proponents, which entice the desperate to try the treatment—regardless of the physical, emotional, and financial expense it may entail. Proponents perceive discrimination when their grant proposals fare poorly in peer review and feel persecuted when regulatory agencies investigate them.
This content is only available as a PDF.
© Oxford University Press
Issue Section:
Commentary
You do not currently have access to this article.